2022 TargetCancer Foundation Gala

The 2022 TargetCancer Foundation Gala
September 21, 2022, 6:00pm ET

 

Tickets are available for purchase here.

TargetCancer Foundation invites you to join us at our 2022 Gala in Boston’s beautiful State Room! We look forward to gathering together for the first time in three years as we celebrate with our wonderful community and raise critical funds for rare cancer research and patient support.

We are pleased to share that Vanessa Welch, Evening News Anchor for Boston25, will return as the Host of the 2022 Gala.

We are honored to welcome this year’s Gala Keynote Speaker, Allen Chankowsky. Allen is an author, marketing expert and 30-year cancer survivor who is currently surviving a rare form of Stage-4 cancer. He is the author of the newly released book, On the Other Side of TERMINAL, which has won three recent awards.

Our crowd-favorite all-you-can-eat oyster bar returns in 2022, thanks to our friends at Sea State Foods. Music will once again be provided by the Dave Fox Trio.

The silent auction is open for bidding! The auction will close at 8:30pm on Wednesday evening. A reminder that you do not need to be at the event to bid! Simply register here.

Special thanks to Spike Events, who is providing a Classic Photo Booth for the Gala!

Recommended attire for the evening is business/cocktail.

TargetCancer Foundation will continue to monitor and update safety precautions for this event, and make decisions that are in the best interest of all attendees based on CDC and state guidelines. All guests must be vaccinated against COVID-19 to attend the Gala.

If you have purchased a ticket but have not received an email with details about how to submit your proof of vaccination, please email: gala@targetcancerfoundation.org with subject: Crowdpass

 

Watch the 2020 Virtual Gala here, and view event photos and red carpet photos from our 10th Anniversary Gala in 2019. Thank you to Gleb Budilovsky Photography.

Can’t make the gala? You can still support the event by making a donation

 

We’re partnering with leading researchers to make a real impact
Learn More